Copyright Reports & Markets. All rights reserved.

Global Neuromodulation Devices and Implantable Infusion Pumps Market Professional Survey Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 Industry Overview of Neuromodulation Devices and Implantable Infusion Pumps

      • 1.1 Definition of Neuromodulation Devices and Implantable Infusion Pumps
      • 1.2 Neuromodulation Devices and Implantable Infusion Pumps Segment by Type
        • 1.2.1 Global Neuromodulation Devices and Implantable Infusion Pumps Production Growth Rate Comparison by Types (2014-2025)
        • 1.2.2 Neuromodulation Devices
        • 1.2.3 Implantable Infusion Pumps
      • 1.3 Neuromodulation Devices and Implantable Infusion Pumps Segment by Applications
        • 1.3.1 Global Neuromodulation Devices and Implantable Infusion Pumps Consumption Comparison by Applications (2014-2025)
        • 1.3.2 Clinic
        • 1.3.3 Hospital
      • 1.4 Global Neuromodulation Devices and Implantable Infusion Pumps Overall Market
        • 1.4.1 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue (2014-2025)
        • 1.4.2 Global Neuromodulation Devices and Implantable Infusion Pumps Production (2014-2025)
        • 1.4.3 North America Neuromodulation Devices and Implantable Infusion Pumps Status and Prospect (2014-2025)
        • 1.4.4 Europe Neuromodulation Devices and Implantable Infusion Pumps Status and Prospect (2014-2025)
        • 1.4.5 China Neuromodulation Devices and Implantable Infusion Pumps Status and Prospect (2014-2025)
        • 1.4.6 Japan Neuromodulation Devices and Implantable Infusion Pumps Status and Prospect (2014-2025)
        • 1.4.7 Southeast Asia Neuromodulation Devices and Implantable Infusion Pumps Status and Prospect (2014-2025)
        • 1.4.8 India Neuromodulation Devices and Implantable Infusion Pumps Status and Prospect (2014-2025)

      2 Manufacturing Cost Structure Analysis

      • 2.1 Raw Material and Suppliers
      • 2.2 Manufacturing Cost Structure Analysis of Neuromodulation Devices and Implantable Infusion Pumps
      • 2.3 Manufacturing Process Analysis of Neuromodulation Devices and Implantable Infusion Pumps
      • 2.4 Industry Chain Structure of Neuromodulation Devices and Implantable Infusion Pumps

      3 Development and Manufacturing Plants Analysis of Neuromodulation Devices and Implantable Infusion Pumps

      • 3.1 Capacity and Commercial Production Date
      • 3.2 Global Neuromodulation Devices and Implantable Infusion Pumps Manufacturing Plants Distribution
      • 3.3 Major Manufacturers Technology Source and Market Position of Neuromodulation Devices and Implantable Infusion Pumps
      • 3.4 Recent Development and Expansion Plans

      4 Key Figures of Major Manufacturers

      • 4.1 Neuromodulation Devices and Implantable Infusion Pumps Production and Capacity Analysis
      • 4.2 Neuromodulation Devices and Implantable Infusion Pumps Revenue Analysis
      • 4.3 Neuromodulation Devices and Implantable Infusion Pumps Price Analysis
      • 4.4 Market Concentration Degree

      5 Neuromodulation Devices and Implantable Infusion Pumps Regional Market Analysis

      • 5.1 Neuromodulation Devices and Implantable Infusion Pumps Production by Regions
        • 5.1.1 Global Neuromodulation Devices and Implantable Infusion Pumps Production by Regions
        • 5.1.2 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Regions
      • 5.2 Neuromodulation Devices and Implantable Infusion Pumps Consumption by Regions
      • 5.3 North America Neuromodulation Devices and Implantable Infusion Pumps Market Analysis
        • 5.3.1 North America Neuromodulation Devices and Implantable Infusion Pumps Production
        • 5.3.2 North America Neuromodulation Devices and Implantable Infusion Pumps Revenue
        • 5.3.3 Key Manufacturers in North America
        • 5.3.4 North America Neuromodulation Devices and Implantable Infusion Pumps Import and Export
      • 5.4 Europe Neuromodulation Devices and Implantable Infusion Pumps Market Analysis
        • 5.4.1 Europe Neuromodulation Devices and Implantable Infusion Pumps Production
        • 5.4.2 Europe Neuromodulation Devices and Implantable Infusion Pumps Revenue
        • 5.4.3 Key Manufacturers in Europe
        • 5.4.4 Europe Neuromodulation Devices and Implantable Infusion Pumps Import and Export
      • 5.5 China Neuromodulation Devices and Implantable Infusion Pumps Market Analysis
        • 5.5.1 China Neuromodulation Devices and Implantable Infusion Pumps Production
        • 5.5.2 China Neuromodulation Devices and Implantable Infusion Pumps Revenue
        • 5.5.3 Key Manufacturers in China
        • 5.5.4 China Neuromodulation Devices and Implantable Infusion Pumps Import and Export
      • 5.6 Japan Neuromodulation Devices and Implantable Infusion Pumps Market Analysis
        • 5.6.1 Japan Neuromodulation Devices and Implantable Infusion Pumps Production
        • 5.6.2 Japan Neuromodulation Devices and Implantable Infusion Pumps Revenue
        • 5.6.3 Key Manufacturers in Japan
        • 5.6.4 Japan Neuromodulation Devices and Implantable Infusion Pumps Import and Export
      • 5.7 Southeast Asia Neuromodulation Devices and Implantable Infusion Pumps Market Analysis
        • 5.7.1 Southeast Asia Neuromodulation Devices and Implantable Infusion Pumps Production
        • 5.7.2 Southeast Asia Neuromodulation Devices and Implantable Infusion Pumps Revenue
        • 5.7.3 Key Manufacturers in Southeast Asia
        • 5.7.4 Southeast Asia Neuromodulation Devices and Implantable Infusion Pumps Import and Export
      • 5.8 India Neuromodulation Devices and Implantable Infusion Pumps Market Analysis
        • 5.8.1 India Neuromodulation Devices and Implantable Infusion Pumps Production
        • 5.8.2 India Neuromodulation Devices and Implantable Infusion Pumps Revenue
        • 5.8.3 Key Manufacturers in India
        • 5.8.4 India Neuromodulation Devices and Implantable Infusion Pumps Import and Export

      6 Neuromodulation Devices and Implantable Infusion Pumps Segment Market Analysis (by Type)

      • 6.1 Global Neuromodulation Devices and Implantable Infusion Pumps Production by Type
      • 6.2 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Type
      • 6.3 Neuromodulation Devices and Implantable Infusion Pumps Price by Type

      7 Neuromodulation Devices and Implantable Infusion Pumps Segment Market Analysis (by Application)

      • 7.1 Global Neuromodulation Devices and Implantable Infusion Pumps Consumption by Application
      • 7.2 Global Neuromodulation Devices and Implantable Infusion Pumps Consumption Market Share by Application (2014-2019)

      8 Neuromodulation Devices and Implantable Infusion Pumps Major Manufacturers Analysis

      • 8.1 Advanced Bionics/Sonova
        • 8.1.1 Advanced Bionics/Sonova Neuromodulation Devices and Implantable Infusion Pumps Production Sites and Area Served
        • 8.1.2 Advanced Bionics/Sonova Product Introduction, Application and Specification
        • 8.1.3 Advanced Bionics/Sonova Neuromodulation Devices and Implantable Infusion Pumps Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.1.4 Main Business and Markets Served
      • 8.2 Cerbomed
        • 8.2.1 Cerbomed Neuromodulation Devices and Implantable Infusion Pumps Production Sites and Area Served
        • 8.2.2 Cerbomed Product Introduction, Application and Specification
        • 8.2.3 Cerbomed Neuromodulation Devices and Implantable Infusion Pumps Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.2.4 Main Business and Markets Served
      • 8.3 Cochlear
        • 8.3.1 Cochlear Neuromodulation Devices and Implantable Infusion Pumps Production Sites and Area Served
        • 8.3.2 Cochlear Product Introduction, Application and Specification
        • 8.3.3 Cochlear Neuromodulation Devices and Implantable Infusion Pumps Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.3.4 Main Business and Markets Served
      • 8.4 ImThera
        • 8.4.1 ImThera Neuromodulation Devices and Implantable Infusion Pumps Production Sites and Area Served
        • 8.4.2 ImThera Product Introduction, Application and Specification
        • 8.4.3 ImThera Neuromodulation Devices and Implantable Infusion Pumps Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.4.4 Main Business and Markets Served
      • 8.5 MED-EL
        • 8.5.1 MED-EL Neuromodulation Devices and Implantable Infusion Pumps Production Sites and Area Served
        • 8.5.2 MED-EL Product Introduction, Application and Specification
        • 8.5.3 MED-EL Neuromodulation Devices and Implantable Infusion Pumps Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.5.4 Main Business and Markets Served
      • 8.6 Neurelec
        • 8.6.1 Neurelec Neuromodulation Devices and Implantable Infusion Pumps Production Sites and Area Served
        • 8.6.2 Neurelec Product Introduction, Application and Specification
        • 8.6.3 Neurelec Neuromodulation Devices and Implantable Infusion Pumps Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.6.4 Main Business and Markets Served
      • 8.7 Boston Scientific
        • 8.7.1 Boston Scientific Neuromodulation Devices and Implantable Infusion Pumps Production Sites and Area Served
        • 8.7.2 Boston Scientific Product Introduction, Application and Specification
        • 8.7.3 Boston Scientific Neuromodulation Devices and Implantable Infusion Pumps Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.7.4 Main Business and Markets Served
      • 8.8 CerebralRx
        • 8.8.1 CerebralRx Neuromodulation Devices and Implantable Infusion Pumps Production Sites and Area Served
        • 8.8.2 CerebralRx Product Introduction, Application and Specification
        • 8.8.3 CerebralRx Neuromodulation Devices and Implantable Infusion Pumps Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.8.4 Main Business and Markets Served
      • 8.9 Codman & Shurtleff (Johnson & Johnson)
        • 8.9.1 Codman & Shurtleff (Johnson & Johnson) Neuromodulation Devices and Implantable Infusion Pumps Production Sites and Area Served
        • 8.9.2 Codman & Shurtleff (Johnson & Johnson) Product Introduction, Application and Specification
        • 8.9.3 Codman & Shurtleff (Johnson & Johnson) Neuromodulation Devices and Implantable Infusion Pumps Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.9.4 Main Business and Markets Served
      • 8.10 Flowonix
        • 8.10.1 Flowonix Neuromodulation Devices and Implantable Infusion Pumps Production Sites and Area Served
        • 8.10.2 Flowonix Product Introduction, Application and Specification
        • 8.10.3 Flowonix Neuromodulation Devices and Implantable Infusion Pumps Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.10.4 Main Business and Markets Served
      • 8.11 Inspire Medical Systems
      • 8.12 LivaNova (formerly Cyberonics)
      • 8.13 Medtronic
      • 8.14 Neuronetics
      • 8.15 NeuroPace
      • 8.16 NeuroSigma
      • 8.17 Nurotron
      • 8.18 St. Jude Medical

      9 Development Trend of Analysis of Neuromodulation Devices and Implantable Infusion Pumps Market

      • 9.1 Global Neuromodulation Devices and Implantable Infusion Pumps Market Trend Analysis
        • 9.1.1 Global Neuromodulation Devices and Implantable Infusion Pumps Market Size (Volume and Value) Forecast 2019-2025
      • 9.2 Neuromodulation Devices and Implantable Infusion Pumps Regional Market Trend
        • 9.2.1 North America Neuromodulation Devices and Implantable Infusion Pumps Forecast 2019-2025
        • 9.2.2 Europe Neuromodulation Devices and Implantable Infusion Pumps Forecast 2019-2025
        • 9.2.3 China Neuromodulation Devices and Implantable Infusion Pumps Forecast 2019-2025
        • 9.2.4 Japan Neuromodulation Devices and Implantable Infusion Pumps Forecast 2019-2025
        • 9.2.5 Southeast Asia Neuromodulation Devices and Implantable Infusion Pumps Forecast 2019-2025
        • 9.2.6 India Neuromodulation Devices and Implantable Infusion Pumps Forecast 2019-2025
      • 9.3 Neuromodulation Devices and Implantable Infusion Pumps Market Trend (Product Type)
      • 9.4 Neuromodulation Devices and Implantable Infusion Pumps Market Trend (Application)
      • 10.1 Marketing Channel
        • 10.1.1 Direct Marketing
        • 10.1.2 Indirect Marketing
      • 10.3 Neuromodulation Devices and Implantable Infusion Pumps Customers

      11 Market Dynamics

      • 11.1 Market Trends
      • 11.2 Opportunities
      • 11.3 Market Drivers
      • 11.4 Challenges
      • 11.5 Influence Factors

      12 Conclusion

        13 Appendix

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        The global Neuromodulation Devices and Implantable Infusion Pumps market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
        This report focuses on Neuromodulation Devices and Implantable Infusion Pumps volume and value at global level, regional level and company level. From a global perspective, this report represents overall Neuromodulation Devices and Implantable Infusion Pumps market size by analyzing historical data and future prospect.
        Regionally, this report categorizes the production, apparent consumption, export and import of Neuromodulation Devices and Implantable Infusion Pumps in North America, Europe, China, Japan, Southeast Asia and India.
        For each manufacturer covered, this report analyzes their Neuromodulation Devices and Implantable Infusion Pumps manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

        The following manufacturers are covered:
        Advanced Bionics/Sonova
        Cerbomed
        Cochlear
        ImThera
        MED-EL
        Neurelec
        Boston Scientific
        CerebralRx
        Codman & Shurtleff (Johnson & Johnson)
        Flowonix
        Inspire Medical Systems
        LivaNova (formerly Cyberonics)
        Medtronic
        Neuronetics
        NeuroPace
        NeuroSigma
        Nurotron
        St. Jude Medical

        Segment by Regions
        North America
        Europe
        China
        Japan
        Southeast Asia
        India

        Segment by Type
        Neuromodulation Devices
        Implantable Infusion Pumps

        Segment by Application
        Clinic
        Hospital

        Buy now